Corebridge Financial’s Zymeworks ZYME Stock Holding History
Bought
Maintained
Sold
Other funds holding ZYME
EC
RCMNY
BI
RG
Corebridge Financial's ZYME Position: Q2 2025 in Review
Corebridge Financial sold out of Zymeworks (ZYME) in Q2 2025, closing a stake of 26,719 shares — an estimated $318K sold.
Corebridge Financial first reported a position in ZYME in Q2 2024 and held it in 4 quarters. The position peaked at $397K in Q4 2024. 181 funds tracked by Wall St. Rank hold ZYME as of Q2 2025.
- Corebridge Financial reported no remaining Zymeworks position as of Q2 2025 after selling out during the quarter.
- Corebridge Financial sold 26,719 Zymeworks shares in Q2 2025, an estimated $318K.
- Corebridge Financial first reported a position in Zymeworks in Q2 2024 and held it in 4 quarters.
- Corebridge Financial's Zymeworks position peaked at $397K in Q4 2024.
- 181 funds tracked by Wall St. Rank held Zymeworks as of Q2 2025.
Based on Corebridge Financial's 13F filing for Q2 2025, filed 12 Aug 2025.